Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2005
03/17/2005US20050059112 Proteases from gram-positive organisms
03/17/2005US20050059111 Pichia methanolica secretory signal
03/17/2005US20050059109 Methods and compositions for polypeptide engineering
03/17/2005US20050059108 Expression vector comprising nucleotide sequences coding neurotransmitter for use in prevention and treatment of obesity, anorexia, energy imbalance, diabetes, dyslipidemia, hypertension and/or insulin resistance
03/17/2005US20050059107 Method of selecting hla-dp4 ligands and the applications thereof
03/17/2005US20050059093 Method for detecting modulators of Notch signalling
03/17/2005US20050059082 Method for producing protein libraries and for selecting proteins from said libraries
03/17/2005US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells
03/17/2005US20050059078 Transgenic cells for use as bioreactors; heterologous gene expression; animal model of disease
03/17/2005US20050059076 Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/17/2005US20050059067 Using restriction fragment length polymorphism in tyrosine kinase varian t as diagnostic tool in detection of cell proliferative and inflammatory disorders
03/17/2005US20050059061 Beta, beta-carotene 15,15'-enzymes, nucleic acid sequences coding therefor and their use
03/17/2005US20050059060 Oligonucleotide for use as gene trapped sequences (GTSs) and tools in detection and recovery of novel genes; genetic engineering and gene expression analysis; genomics; forensic analysis
03/17/2005US20050059059 Novel nucleic acid based steganography system and application thereof
03/17/2005US20050059058 Oligonucleotide sequences coding integral membrane proteins (ZIPA) for use as tool in identifying bactericidal agents; microbiocides; drug screening
03/17/2005US20050059057 Method of parallel screening for insertion mutants and a kit to perform this method
03/17/2005US20050059054 Isolating RNA from prepared tissues; contact tissue sample with digestion buffer comprising polyanion and protease, recover lysis mixture, recover ribonucleic acid from lysate; gene expression analysis
03/17/2005US20050059053 Generating plants comprising polypeptides with enhanced properties; directed evolution of proteins; bioreactor and heterologous gene expression
03/17/2005US20050059050 Novel human ion-exchanger proteins and polynucleotides encoding the same
03/17/2005US20050059047 Expression vector comprising nucleotide sequences coding 26S protease regulatory subunit 8 (SUG-1) for use tool to enhance transcription of heterologous sequences in transgenic plants
03/17/2005US20050059044 Small interfering RNA sequences for use as gene silencing tools; gene expression inhibition
03/17/2005US20050059040 Guidance receptor protein for use as tool in identifying modlator for use in treatment and preventio of nervous system disorders
03/17/2005US20050059038 Screening mixture and identifying modulators for treatment and prevention of cell proliferative, nervous system, inflammatory and eating disorders
03/17/2005US20050059037 Undergoing a change in the fluorescent signal intensity depending on the corresponding base type in the partner strand with which the single-stranded sequence is hybridized
03/17/2005US20050059029 Derivatized versions of ligase enzymes for constructing DNA sequences
03/17/2005US20050059028 RNAi-based sensors, caged interfering RNAs, and methods of use thereof
03/17/2005US20050059024 Isolating, extracting, purifying, characterizing, quantifying, and/or assaying micro-nucleotide sequences; gene expression inhibition; isolating RNA of less than 100 base pairs
03/17/2005US20050059022 Oligonucleotide sequence comprising two tags (ditag) for use tool in gene discovery and genetic mapping; gene expression analysis; sequencing enhancement
03/17/2005US20050059019 Gene-related RNAi transfection method
03/17/2005US20050059016 Structural motifs and oligomeric compounds and their use in gene modulation
03/17/2005US20050059009 Using iodophor conjugated nucleotide sequences as diagnostic tool in detection of preferential nucleotide sequences in sample; gene expression analysis
03/17/2005US20050059008 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
03/17/2005US20050059006 Using presence of polymorphism in ciliary neurotrophic factor (CNTF) gene sequences as diagnostic indicator for lloperidone treatment of psychotic disorders
03/17/2005US20050059005 Microrna molecules
03/17/2005US20050059004 Nucleotide sequences coding translational regulatory element comprising adenine rich regions for use in activation of cap-independent translation of a nucleotide sequence of interest in eukaryotic cells or organisms; translation and heterologous gene expression
03/17/2005US20050059002 Novel serine protease
03/17/2005US20050059001 Nucleic acids isolated in neuroblastoma
03/17/2005US20050058999 Gene involved in apoptosis regulation
03/17/2005US20050058998 Amino acid and nucleic acid sequences of cyclic nucleotide phosphodiesterases that are involved in T cell activation and may be used in the diagnosis and treatment of disorders such as autoimmune diseases
03/17/2005US20050058994 Epitopes; immunoglobulins; hybridomas; diagnostic kits
03/17/2005US20050058989 Grapevine leafroll virus proteins and their uses
03/17/2005US20050058988 for identification and vaccination of human papillomavirus;
03/17/2005US20050058987 Reverse genetics system for screening viricides; immunotherapy
03/17/2005US20050058984 Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
03/17/2005US20050058983 Immunoglobulin which specifically binds to lymphadenopathy associated viral glycoprotein 120 for use as tool in prevention and treatment of viral infection; immunotherapy
03/17/2005US20050058982 Modified small interfering RNA molecules and methods of use
03/17/2005US20050058981 Using nested amplification to identify variation in lymphadenoapthy associated viral polymerase gene sequences; viricides
03/17/2005US20050058747 For use in animal feed, in particular fish feed, and detergents
03/17/2005US20050058665 Genetic engineering of a cell-free mixture with Dna segment linked to promoter for binding and detection with reporter genes for treatment of diptheria
03/17/2005US20050058662 Novel type III secretion pathway in Aeromonas salmonicida, and uses therefor
03/17/2005US20050058660 Novel surface antigen
03/17/2005US20050058659 Forming fusion peptides with 14 to 75 amino acids in prokaryotic host cell and encoding fusion peptide for expression vectors
03/17/2005US20050058657 Vaccines for treatment of Aids
03/17/2005US20050058656 Peptide sequences for immunization in veterinary medicine
03/17/2005US20050058655 Vaccine and kit for viral disease in swine and diagnosis of diseases
03/17/2005US20050058651 Compositions and methods to prevent metastasis from primary malignancies
03/17/2005US20050058650 Administering polypeptides to prevent cell proliferation for cancer treatment with hydrolytic enzymes
03/17/2005US20050058648 Antibodies against caspase-8, their preparation and use
03/17/2005US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds
03/17/2005US20050058642 Antagonists and agonists of LDCAM and methods of use
03/17/2005US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
03/17/2005US20050058633 Stem cells that transform to beating cardiomyocytes
03/17/2005US20050058626 Vaccine against pathogens
03/17/2005US20050058624 Fusion proteins; adjust half-life; septic shock, diabetes, antiinflammatory agents
03/17/2005US20050058604 Phthalamide-lanthanide complexes for use as luminescent markers
03/17/2005US20050055780 Redeposition or backstain inhibition during stonewashing process
03/17/2005CA2540198A1 Tick engorgement factor proteins
03/17/2005CA2538319A1 Antibodies against interleukin-1 receptor and uses thereof
03/17/2005CA2538012A1 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof
03/17/2005CA2537995A1 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection
03/17/2005CA2537953A1 Lentivirus vector-based approaches for generating an immune response to hiv in humans
03/17/2005CA2537881A1 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene
03/17/2005CA2537844A1 Treatment of neurodegenerative diseases
03/17/2005CA2537273A1 Method for the production of fusion proteins in transgenic mammal milk
03/17/2005CA2537145A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof
03/17/2005CA2536934A1 Method for differentiating mesenchymal stem cell into hepatocyte and artificial human hepatocyte
03/17/2005CA2536793A1 Novel ubp8rp polypeptides and their use in the treatment of psoriasis
03/17/2005CA2536782A1 Recombinant production of antimicrobial agents
03/17/2005CA2536650A1 Transformed plants with improved growth characteristics due to increased expression of b-type cdk and methods for making same
03/17/2005CA2536099A1 Partitioning of recombinant proteins into e.coli supernatant or periplasm
03/17/2005CA2536015A1 Modified oligonucleotides for telomerase inhibition
03/17/2005CA2535770A1 Method for detecting cancer cells and monitoring cancer therapy
03/17/2005CA2535734A1 Composition for the prevention/treatment of hbv infections and hbv-mediated diseases
03/17/2005CA2535653A1 Novel microorganism and method of treating organic solid matters with the use of the microorganism
03/17/2005CA2517264A1 Ebola peptides and immunogenic compositions containing same
03/16/2005EP1515437A1 Transfection high-voltage controller
03/16/2005EP1514941A2 Paraquat resistance gene and a vascular tissue- and trichome-specific promotor
03/16/2005EP1514940A1 Chondroitin synthetase and dna coding for the enzyme
03/16/2005EP1514939A1 Chondroitin synthetase and nucleic acid coding for the enzyme
03/16/2005EP1514938A1 Heat-resistant DNA ligase
03/16/2005EP1514937A1 Production of vaccines
03/16/2005EP1514936A2 A novel method to isolate mutants and to clone the complementing gene
03/16/2005EP1514935A1 Ehd1 gene promoting plant floewering, and utilization thereof
03/16/2005EP1514934A2 Biosynthetic binding protein for cancer marker
03/16/2005EP1514933A1 Secretory protein or membrane protein
03/16/2005EP1514932A2 Glucagon receptors
03/16/2005EP1514931A1 Immunosuppressant target proteins
03/16/2005EP1514930A1 Novel screening method
03/16/2005EP1514929A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells
03/16/2005EP1514928A1 Method of constructing antibody
1 ... 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 ... 4023